4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-057118
Director sold 21,161 shares at an average $50.09 ($1,059,956)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prokupets Elena Director | 2021-09-17 | Sale | −5,152 | $50.04 | $257,808 | 48,024 | I: show line 1 in the form |
| Prokupets Elena Director | 2021-09-17 | Sale | −5,688 | $50.05 | $284,687 | 531,697 | I: show line 2 in the form |
| Prokupets Elena Director | 2021-09-21 | Sale | −4,988 | $50.13 | $250,051 | 43,036 | I: show line 3 in the form |
| Prokupets Elena Director | 2021-09-21 | Sale | −5,333 | $50.14 | $267,410 | 526,364 | I: show line 4 in the form |
| Open-market sales · 21,161 sh · avg $50.09 · $1,059,956 | |||||||
Loading xslF345X03/doc4.xml…